Operator
Good afternoon. Thank you for joining us today to discuss OptimizeRx Corporation's fourth-quarter and full year ended December 31, 2020. With us today is the chief executive officer of OptimizeRx, William Febbo; and the company's president and chief strategy officer, Miriam Paramore. They are joined by company chief financial officer, Doug Baker; and chief commercial officer, Stephen Silvestro.
Following their remarks, they will open the call for questions. Before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during today's call. I'd like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release and the Investors section of the company's website. Now I'd like to turn the call over to OptimizeRx CEO, Will Febbo.